Stem Cell Biology and Stem Cell Therapy
Karen Aboody, M.D.
Karen Aboody, M.D., professor in the Department of Developmental and Stem Cell Biology, received her M.D. from Mount Sinai School of Medicine. A major research focus of her laboratory is to modify and develop human neural stem cells into a novel therapeutic vehicle for delivering different cancer therapeutic agents to tumor sites in animal models.
Karen Aboody, M.D., professor in the Department of Developmental and Stem Cell Biology, received her M.D. from Mount Sinai School of Medicine. A major research focus of her laboratory is to modify and develop human neural stem cells into a novel therapeutic vehicle for delivering different cancer therapeutic agents to tumor sites in animal models.
Michael Barish, Ph.D.
Michael Barish, professor in the Department of Developmental and Stem Cell Biology, received his Ph.D. from Stanford University. His team is using large-field imaging techniques to visualize tumor initiating cells in patient-derived tumor xenografts, and the spatial relationships of migrating tumor cells and the sites of proliferation and engraftment.
Michael Barish, professor in the Department of Developmental and Stem Cell Biology, received his Ph.D. from Stanford University. His team is using large-field imaging techniques to visualize tumor initiating cells in patient-derived tumor xenografts, and the spatial relationships of migrating tumor cells and the sites of proliferation and engraftment.
Angelo Cardoso, M.D., Ph.D.
Angelo Cardoso, M.D., Ph.D., research professor and director of the Laboratory for Cellular Medicine in the Center for Gene Therapy, received his M.D. and Ph.D. from Porto University and University of Paris XI Medical School, respectively. He studies how oncogenic signals interact with micro-environmental cues in an attempt to develop novel inhibitors targeting high-risk and refractory relapsed pediatric acute lymphoblastic leukemia.
Angelo Cardoso, M.D., Ph.D., research professor and director of the Laboratory for Cellular Medicine in the Center for Gene Therapy, received his M.D. and Ph.D. from Porto University and University of Paris XI Medical School, respectively. He studies how oncogenic signals interact with micro-environmental cues in an attempt to develop novel inhibitors targeting high-risk and refractory relapsed pediatric acute lymphoblastic leukemia.
Qiang Lu, Ph.D.
Qiang Lu, Ph.D., professor in the Department of Developmental and Stem Cell Biology, received his Ph.D. from the University of California San Diego. His research is directed at understanding how neural stem cells decide to maintain their stemness or differentiate with the ultimate goal directed at developing treatments for brain cancers.
Qiang Lu, Ph.D., professor in the Department of Developmental and Stem Cell Biology, received his Ph.D. from the University of California San Diego. His research is directed at understanding how neural stem cells decide to maintain their stemness or differentiate with the ultimate goal directed at developing treatments for brain cancers.
Yanhong Shi, Ph.D.
Yanhong Shi, Ph.D., the Herbert Horvitz Professor in Neuroscience, professor and director of the Division of Stem Cell Biology Research, received her Ph.D. from Northwestern University. Her laboratory focuses on characterizing the role of the nuclear receptor TLX signaling in neural stem cell self-renewal and differentiation for developing new treatment against neurological disorders.
Yanhong Shi, Ph.D., the Herbert Horvitz Professor in Neuroscience, professor and director of the Division of Stem Cell Biology Research, received her Ph.D. from Northwestern University. Her laboratory focuses on characterizing the role of the nuclear receptor TLX signaling in neural stem cell self-renewal and differentiation for developing new treatment against neurological disorders.